Other maltreatment syndromes

VWXY20_OTHER_MALTR_SYNDR1

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Y07 Cause of death: ICD-10 — Y07 2 out of 7 registries used, show all original rules.	1265
4. Check minimum number of events None	1265
5. Include endpoints None	1265
6. Filter based on genotype QC (FinnGen only)	1265

Control definitions (FinnGen only)

Control exclude: VWXY20_ASSAULT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X85-Y09

NAME	VWXY20_OTHER_MALTR_SYNDR1
CONTROL_EXCLUDE	VWXY20_ASSAULT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Y07
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Y07
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other maltreatment syndromes based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1265	480	785
Unadjusted period prevalence (%)	0.28	0.16	0.35
Median age at first event (years)	37.00	38.77	35.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1123: Matched controls
11230

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Y07

ICD-10 Finland

Other maltreatment

+∞

323.0

1099

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

45.0

217.5

269

T74.1

ICD-10 Finland

Physical abuse

43.9

212.3

264

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

1968.1

172.5

163

DHD10

NOMESCO Finland

Closed reduction of fracture of nose

67.9

150.9

173

S06.0

ICD-10 Finland

Concussion

8.2

127.8

319

519

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

8.7

120.9

287

427

Z2221

NOMESCO Finland

Medical doctor

4.5

109.7

518

1783

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

5.9

108.1

356

825

T36

ICD-10 Finland

Poisoning by systemic antibiotics

10.9

106.8

217

241

Z3231

NOMESCO Finland

Registered nurse

4.5

104.8

486

1626

R4110

NOMESCO Finland

Physiotherapy

4.5

101.9

464

1515

N05AH04

ATC

quetiapine; oral

4.9

101.7

408

1170

X59

ICD-10 Finland

Exposure to unspecified factor

4.5

95.8

428

1354

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

11.2

93.7

186

195

ZXD05

NOMESCO Finland

Urgent procedure

3.8

87.4

522

2106

ZXE00

NOMESCO Finland

One hour or less

3.6

86.4

588

2629

ZXE10

NOMESCO Finland

More than one and less than three hours

3.7

85.1

533

2219

N05BA01

ATC

diazepam; systemic, rectal

5.5

84.9

288

667

ZXD10

NOMESCO Finland

Scheduled procedure

3.6

84.5

543

2304

P15

ICPC

Chronic alcohol abuse

10.8

84.3

170

182

ZXD35

NOMESCO Finland

Usual procedure

12.9

83.6

154

137

Z2446

NOMESCO Finland

Social worker

7.3

83.5

218

359

Z3226

NOMESCO Finland

Physiotherapist

4.6

82.8

343

983

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

60.9

81.5

N07BB01

ATC

disulfiram; oral

7.8

81.1

200

302

N06AX11

ATC

mirtazapine; oral

3.6

79.0

494

2023

N06AB04

ATC

citalopram; systemic

4.1

77.9

379

1253

Y09

ICD-10 Finland

Assault by unspecified means

+∞

77.0

AA1AD

NOMESCO Finland

CT of head and brain

4.3

76.5

340

1031

N05CF01

ATC

zopiclone; oral

3.6

75.3

436

1663

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

13.0

72.9

133

115

S02.40

ICD-10 Finland

Fracture of malar and maxillary bones, closed

38.0

71.4

S01.0

ICD-10 Finland

Open wound of scalp

6.6

70.2

195

345

F10.09

ICD-10 Finland

Alcohol intoxication UNS

13.9

67.9

120

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

+∞

67.4

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

10.6

67.3

136

144

N05BA04

ATC

oxazepam; oral

3.6

67.3

385

1428

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.9

66.2

243

598

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.2

65.0

291

871

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.3

64.9

420

1704

F10.25

ICD-10 Finland

Alcohol dependence continuous use

16.1

64.2

106

ZXA05

NOMESCO Finland

Left side

3.6

62.2

343

1222

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

13.7

58.8

104

XF400

NOMESCO Finland

ECG with 12 standard connections

4.3

58.5

243

671

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

12.3

58.2

108

S00.8

ICD-10 Finland

Superficial injury of other parts of head

19.5

56.8

B18.2

ICD-10 Finland

Chronic viral hepatitis C

13.4

56.7

101

N06AX16

ATC

venlafaxine; oral

3.7

53.6

272

891

WX408

NOMESCO Finland

General anesthesy, balanced

3.0

53.4

388

1659

N05CD07

ATC

temazepam; oral

5.2

53.0

178

391

Y04.2

ICD-10 Finland

Assault by bodily force by friend

+∞

52.5

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

+∞

52.5

ZXA00

NOMESCO Finland

Right side

3.2

51.9

332

1296

P16

ICPC

Acute alcohol abuse

11.8

50.9

F10.20

ICD-10 Finland

Alcohol dependence currently independent

10.9

49.7

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

4.6

49.6

188

468

Z71.8

ICD-10 Finland

Other specified counselling

2.9

48.9

371

1616

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

8.6

47.0

106

135

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

9.7

45.9

107

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

12.2

45.8

N02AX02

ATC

tramadol; systemic, rectal

2.5

45.6

511

2779

NA1AD

NOMESCO Finland

Cervical spine CT examination

7.7

45.5

110

156

ZXD20

NOMESCO Finland

Day surgery

3.6

44.0

224

724

N05AA02

ATC

levomepromazine; systemic

6.7

43.6

116

189

F10.24

ICD-10 Finland

Alcohol depence active use

14.0

43.2

P19

ICPC

Drug abuse

13.8

42.9

N06AB03

ATC

fluoxetine; oral

3.8

42.9

204

622

N05AH03

ATC

olanzapine; systemic

4.5

42.9

165

414

N03AX16

ATC

pregabalin; oral

2.9

41.5

296

1218

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

12.9

41.2

C07AA05

ATC

propranolol; systemic

2.9

40.6

290

1190

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.8

40.4

312

1347

R4120

NOMESCO Finland

Occupational therapy

5.1

39.6

132

284

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

8.7

39.3

107

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

13.1

38.7

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

16.8

38.6

S22.3

ICD-10 Finland

Fracture of rib

5.3

38.5

125

261

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

13.3

38.5

N05BA12

ATC

alprazolam; oral

3.9

37.7

171

497

SPAT1265

SPAT

Breathalyser

13.1

37.7

N02BE01

ATC

paracetamol; systemic, rectal

2.7

37.6

942

7396

X58

ICD-10 Finland

Exposure to other specified factors

2.9

37.3

260

1041

N06AB10

ATC

escitalopram; oral

2.6

37.1

325

1499

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

10.1

37.0

N05BA02

ATC

chlordiazepoxide; systemic

9.8

36.5

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

36.4

269

1119

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

11.6

36.1

P18

ICPC

Medication abuse

16.5

35.9

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.9

35.8

125

282

WX002

NOMESCO Finland

Sedation and analgesia

3.0

35.7

245

969

N06AB05

ATC

paroxetine; oral

4.5

35.5

135

333

WX110

NOMESCO Finland

Local anesthesy

2.4

35.4

857

6465

WX290

NOMESCO Finland

Other blockade of nerve

2.2

35.2

649

4303

A02BC02

ATC

pantoprazole; systemic

2.2

34.8

683

4650

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.2

34.7

626

4102

W19

ICD-10 Finland

Unspecified fall

3.8

34.7

161

476

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

21.3

34.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.4

34.6

188

628

N06AB06

ATC

sertraline; oral

3.3

34.6

195

672

R74

ICPC

Upper respiratory infection acute

2.3

34.4

423

2319

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

5.3

34.0

108

219

F51.0

ICD-10 Finland

Nonorganic insomnia

3.0

34.0

219

828

N05CF02

ATC

zolpidem; oral

2.8

33.9

257

1079

S00.0

ICD-10 Finland

Superficial injury of scalp

10.7

33.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

33.6

437

2454

SAA01

NOMESCO Finland

Simple examination of mouth

2.4

33.5

873

6711

M54.5

ICD-10 Finland

Low back pain

2.3

33.1

425

2367

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.2

33.0

518

3160

N06AA12

ATC

doxepin; systemic

6.4

33.0

151

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.6

32.7

119

280

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

11.9

32.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.8

32.3

146

421

EBA00

NOMESCO Finland

Extraction of tooth

2.2

31.8

445

2565

K02.1

ICD-10 Finland

Caries of dentine

2.1

31.8

744

5365

D11

ICPC

Diarrhoea

3.1

31.5

198

734

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.3

31.4

124

316

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

+∞

31.4

P74

ICPC

Anxiety disorder/anxiety state

5.1

31.4

103

217

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.1

31.3

689

4821

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

5.4

31.2

196

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.4

31.2

120

298

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

13.1

31.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

30.9

555

3556

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

4.3

30.9

121

306

TKC20

NOMESCO Finland

Catheterisation of bladder

5.2

30.8

100

208

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.3

30.7

168

561

Z72.1

ICD-10 Finland

Alcohol use

11.7

30.6

Z2445

NOMESCO Finland

Psychologist

4.9

30.5

104

228

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

30.0

427

2464

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.6

29.9

259

1169

M79.6

ICD-10 Finland

Pain in limb

2.2

29.8

399

2239

QAB00

NOMESCO Finland

Suture of skin of head or neck

12.3

29.7

Z72.2

ICD-10 Finland

Drug use

17.7

29.4

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.6

29.4

N03AG01

ATC

valproic acid; systemic, rectal

3.9

29.3

127

352

L03

ICPC

Low back symptom/complaint

2.4

29.2

289

1398

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.9

29.0

127

355

P29

ICPC

Psychological sympt/compl other

3.7

28.9

137

410

WX892

NOMESCO Finland

Monitored bed care

4.3

28.9

114

290

S20.2

ICD-10 Finland

Contusion of thorax

4.8

28.8

100

224

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

3.3

28.6

159

538

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

24.3

28.4

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

4.9

28.4

213

N05AX08

ATC

risperidone; systemic

3.7

28.2

130

380

ZY010

NOMESCO Finland

Hospital outpatient

4.1

28.1

117

313

L12

ICPC

Hand/finger symptom/complaint

2.9

28.1

185

705

ZXE20

NOMESCO Finland

More than three and less than five hours

3.1

28.1

172

624

EDC38

NOMESCO Finland

Open reduction and fixation of fracture of body of mandible

65.8

28.1

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.2

27.9

111

284

EEC35

NOMESCO Finland

Reduction and osteosynthesis of zygomaticomaxillary fracture

79.7

27.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

27.9

184

702

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

10.6

27.7

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

7.5

27.4

-1

NOMESCO Finland

2.1

27.3

460

2826

N80

ICPC

Head injury other

13.1

27.3

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.1

27.0

133

P01

ICPC

Feeling anxious/nervous/tense

2.8

26.9

191

759

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.5

26.9

133

411

S18

ICPC

Laceration/cut

2.1

26.8

423

2524

N03AE01

ATC

clonazepam; systemic

4.4

26.7

101

246

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

20.2

26.2

KMAK

NOMESCO Finland

2.0

26.0

677

4889

W00

ICD-10 Finland

Fall on same level involving ice and snow

3.1

26.0

155

549

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.1

25.9

105

274

P01AB01

ATC

metronidazole; oral, rectal

2.1

25.8

422

2545

F43.1

ICD-10 Finland

Post-traumatic stress disorder

6.0

25.8

129

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

25.6

458

2862

J01DB01

ATC

cefalexin; oral

2.2

25.5

931

7671

W22

ICD-10 Finland

Striking against or struck by other object(s)

3.3

25.5

141

473

EB1AA

SPAT

4.3

25.5

248

N05BE01

ATC

buspirone; oral

6.3

25.3

116

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

13.9

25.2

WX110

SPAT

4.1

25.0

101

262

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

4.5

24.6

217

D10

ICPC

Vomiting

3.4

24.3

124

392

A28

ICPC

Limited function/disability NOS

3.5

23.8

117

359

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

23.7

217

994

F60.9

ICD-10 Finland

Personality disorder, unspecified

8.2

23.7

P03

ICPC

Feeling depressed

2.9

23.6

157

598

N01

ICPC

Headache

3.0

23.3

147

542

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

17.7

23.2

WX730

NOMESCO Finland

Conventional respirator

11.4

23.0

TQW40

NOMESCO Finland

Remowal of suture of skin

3.6

23.0

109

325

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.1

23.0

304

1661

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

4.8

23.0

175

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

12.5

22.9

CAC10

NOMESCO Finland

Reconstruction of orbital wall using bone graft or plate

33.0

22.5

R05

ICPC

Cough

2.3

22.5

251

1268

X57

ICD-10 Finland

Unspecified privation

6.7

22.4

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

3.5

22.4

112

349

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

14.7

22.2

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.9

22.2

163

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.8

22.2

152

589

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.4

22.1

207

957

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.8

22.1

164

S62.6

ICD-10 Finland

Fracture of other finger

4.0

22.1

246

V03AA01

ATC

9.2

22.0

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.0

22.0

139

512

Y00.9

ICD-10 Finland

Assault by blunt object by unknown person

+∞

21.9

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

21.9

265

1386

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

17.5

21.9

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.2

21.9

269

1420

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

22.7

21.8

S06.2

ICD-10 Finland

Diffuse brain injury

12.6

21.4

L02

ICPC

Back symptom/complaint

3.1

21.4

128

454

A01

ICPC

Pain general/multiple sites

3.8

21.4

258

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.8

21.3

161

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.9

21.3

479

3191

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.8

21.3

P06

ICPC

Sleep disturbance

2.8

21.2

145

558

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.7

21.2

271

F61.0

ICD-10 Finland

Mixed personality disorders

6.3

21.1

R53

ICD-10 Finland

Malaise and fatigue

2.3

21.0

219

1068

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

6.4

21.0

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.9

20.9

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

4.7

20.8

165

N03AX12

ATC

gabapentin; oral

2.5

20.8

182

810

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

20.8

361

2187

N06AX21

ATC

duloxetine; oral

2.8

20.7

147

581

S02.60

ICD-10 Finland

Fracture of mandible, closed

42.5

20.5

N05AB01

ATC

dixyrazine; systemic

12.8

20.4

D01

ICPC

Abdominal pain/cramps general

2.8

20.4

141

547

W10

ICD-10 Finland

Fall on and from stairs and steps

4.2

20.2

199

SPAT1272

SPAT

Drug screening

17.7

20.1

A46

ICD-10 Finland

Erysipelas

2.7

20.1

152

622

S82.6

ICD-10 Finland

Fracture of lateral malleolus

3.6

20.0

273

S02.62

ICD-10 Finland

Fracture of the condyle of the lower jaw

23.9

20.0

SXC03

NOMESCO Finland

Other oral or dental procedure

12.9

20.0

A29

ICPC

General symptom/complaint other

3.1

19.9

117

407

P76

ICPC

Depressive disorder

3.1

19.9

114

392

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

4.7

19.8

155

M01AE01

ATC

ibuprofen; systemic, rectal

2.6

19.8

1041

9298

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

19.7

110

371

Y87.1

ICD-10 Finland

Sequelae of assault

106.9

19.6

XA800

NOMESCO Finland

Neuropsychological investigation

4.0

19.6

210

N05AF03

ATC

chlorprothixene; systemic

5.1

19.4

127

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.4

19.4

168

Y34

ICD-10 Finland

Unspecified event, undetermined intent

18.6

19.2

J01FF01

ATC

clindamycin; systemic

2.0

19.1

313

1840

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

4.2

19.1

185

R51.80

ICD-10 Finland

Headache

2.3

19.0

188

889

S02.80

ICD-10 Finland

Fractures of other skull and facial bones, closed

56.0

19.0

J01DA01

ATC

[U] cefalexin; systemic

1.8

18.9

684

5249

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

18.9

109

377

F60.2

ICD-10 Finland

Dissocial personality disorder

17.5

18.8

XF600

NOMESCO Finland

Bloodpressure measurement

3.7

18.8

234

M03BC01

ATC

orphenadrine (citrate); systemic

2.0

18.7

310

1830

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

12.6

18.7

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.7

18.6

135

540

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

39.1

18.6

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

18.5

180

844

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

18.4

187

895

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

18.4

140

575

L17

ICPC

Foot/toe symptom/complaint

2.1

18.4

238

1273

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

12.1

18.4

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.8

18.3

126

488

R02

ICPC

Shortness of breath/dyspnoea

2.8

18.3

126

489

N03AX09

ATC

lamotrigine; oral

3.4

18.2

294

V01.9

ICD-10 Finland

Pedestrian injured in collision with pedal cycle, Unspecified whether traffic or nontraffic accident

22.1

18.2

A06AD11

ATC

lactulose; oral

2.8

18.2

123

472

QCB00

NOMESCO Finland

Suture of skin of upper limb

7.0

18.2

WX203

NOMESCO Finland

Infraclavicular plexus blockade

6.3

18.0

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

8.9

18.0

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.8

17.9

222

R21

ICPC

Throat symptom/complaint

2.0

17.9

265

1495

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

8.4

17.8

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

7.2

17.8

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.5

17.7

256

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

6.3

17.7

K92.0

ICD-10 Finland

Haematemesis

6.9

17.7

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

17.7

242

1322

T51.0

ICD-10 Finland

Toxic effect: Ethanol

12.7

17.7

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.8

17.7

116

437

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

17.5

377

2432

ED1AA

NOMESCO Finland

Mandipular X-ray examination

15.9

17.5

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

15.9

17.5

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

5.0

17.4

116

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

3.8

17.4

202

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

17.3

326

S80.0

ICD-10 Finland

Contusion of knee

3.1

17.3

334

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

8.7

17.3

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

3.0

17.2

104

371

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

15.1

17.2

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.7

17.0

211

S06.3

ICD-10 Finland

Focal brain injury

10.9

17.0

S09.9

ICD-10 Finland

Unspecified injury of head

12.3

16.9

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

2.0

16.8

246

1376

WX872

NOMESCO Finland

Intensive care

3.9

16.8

188

J20

ICD-10 Finland

Acute bronchitis

2.8

16.7

113

432

S09.2

ICD-10 Finland

Traumatic rupture of ear drum

15.3

16.7

Z71.9

ICD-10 Finland

Counselling, unspecified

3.4

16.7

263

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

12.9

16.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

16.7

269

S29

ICPC

Skin symptom/complaint other

2.3

16.6

166

787

A11

ICPC

Chest pain NOS

3.3

16.6

281

N06AX03

ATC

mianserin; oral

3.9

16.6

185

M01AB05

ATC

diclofenac; systemic, rectal

1.7

16.5

732

5847

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

23.4

16.5

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

20.4

16.5

A03

ICPC

Fever

2.0

16.5

224

1217

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.6

16.4

228

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.1

16.3

318

EFB40

NOMESCO Finland

Removal of internal or external fixation device from facial bones

17.0

16.1

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

3.6

16.1

216

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

5.4

16.0

R03AC02

ATC

salbutamol; inhalant

1.7

16.0

554

4103

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.7

15.9

464

3268

N05AX12

ATC

aripiprazole; systemic

3.2

15.9

284

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

15.8

178

890

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.9

15.8

173

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

2.5

15.7

130

559

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.8

15.6

104

395

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.0

15.6

334

Z72.0

ICD-10 Finland

Tobacco use

5.1

15.5

100

SPAT1227

SPAT

Substance abuse rehabilitation

9.1

15.5

WX320

NOMESCO Finland

Spinalanesthesy

2.0

15.5

208

1122

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

15.5

184

940

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

4.7

15.4

114

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.8

15.3

105

405

ZY000

NOMESCO Finland

Hospital inpatient

6.6

15.3

Z3229

NOMESCO Finland

Other healthcare associate professional

2.8

15.3

101

381

T90.5

ICD-10 Finland

Sequelae of intracranial injury

7.7

15.2

R11

ICD-10 Finland

Nausea and vomiting

2.9

15.2

334

S02.10

ICD-10 Finland

Fracture of base of skull, closed

18.0

15.2

S10

ICPC

Boil/carbuncle

3.3

15.0

245

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

6.6

15.0

SFA40

NOMESCO Finland

Replacement of krone of tooth

2.0

14.9

215

1192

N07BA03

ATC

varenicline; oral

2.8

14.9

357

S00.7

ICD-10 Finland

Multiple superficial injuries of head

12.6

14.9

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

12.6

14.9

RS220

NOMESCO Finland

7.3

14.8

Z25

ICPC

Assault/harmful event problem

11.5

14.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

14.8

241

1398

S02.2

ICD-10 Finland

Fracture of nasal bones

25.4

14.7

A04

ICPC

Weakness/tiredness general

2.4

14.7

131

585

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

3.2

14.6

250

Y07.9

ICD-10 Finland

Other maltreatment by unspecified person

+∞

14.6

Y00.8

ICD-10 Finland

Assault by blunt object by other known person

+∞

14.6

S02.67

ICD-10 Finland

Multiple fracture of the lower jaw

81.2

14.6

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

4.6

14.6

112

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.9

14.5

161

S70.0

ICD-10 Finland

Contusion of hip

4.9

14.4

100

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.5

14.3

121

525

A97

ICPC

No disease

2.2

14.3

149

719

S02.61

ICD-10 Finland

Fracture of mandible, open

27.6

14.3

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

14.3

335

N06AX05

ATC

trazodone; oral

5.1

14.3

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

14.3

602

4652

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

9.3

14.3

SPAT1234

SPAT

Support of social functional capacity

4.4

14.2

120

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

14.1

251

1501

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

14.6

14.1

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.2

14.1

135

S01.8

ICD-10 Finland

Open wound of other parts of head

8.5

14.1

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

30.4

13.9

S22.4

ICD-10 Finland

Multiple fractures of ribs

6.4

13.9

H01

ICPC

Ear pain/earache

2.4

13.9

126

567

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

13.8

138

653

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

13.8

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.3

13.7

119

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

7.7

13.7

F05.9

ICD-10 Finland

Delirium, unspecified

6.7

13.6

S00.3

ICD-10 Finland

Superficial injury of nose

8.1

13.6

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.9

13.6

298

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.9

13.6

S02.31

ICD-10 Finland

Fracture of orbital floor, open

+∞

13.6

Y00.0

ICD-10 Finland

Assault by blunt object by spouse or partner

+∞

13.6

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

13.5

663

5290

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.0

13.5

270

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

13.5

129

596

P99

ICPC

Psychological disorders other

3.7

13.5

161

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

7.9

13.4

B86

ICD-10 Finland

Scabies

5.3

13.4

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

18.5

13.4

NC2AA

NOMESCO Finland

Forearm X-ray examination

8.2

13.3

EBA00

SPAT

4.6

13.3

104

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

5.3

13.3

WX290

SPAT

3.9

13.3

143

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

13.2

333

2218

R52.9

ICD-10 Finland

Pain, unspecified

2.6

13.1

102

423

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

15.3

13.1

JN4BD

NOMESCO Finland

Extensive body CT

2.6

13.1

387

C07AB07

ATC

bisoprolol; oral

1.7

13.0

329

2191

N05AB03

ATC

perphenazine; systemic, rectal

3.6

13.0

171

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

28.7

13.0

M79.1

ICD-10 Finland

Myalgia

2.2

13.0

142

700

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

4.9

12.9

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.5

12.9

183

S01.7

ICD-10 Finland

Multiple open wounds of head

11.7

12.8

P27

ICPC

Fear of mental disorder

6.1

12.8

QBB00

NOMESCO Finland

Suture of skin of trunk

15.6

12.6

P17

ICPC

Tobacco abuse

6.3

12.6

EBA30

NOMESCO Finland

Excision of root of tooth

3.1

12.6

240

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.4

12.6

Y94.8

ICD-10 Finland

Other leisure activity accident

4.1

12.6

125

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

2.2

12.6

135

660

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

8.8

12.5

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

17.5

12.5

Y08.9

ICD-10 Finland

Assault by other specified means by unknown person

+∞

12.5

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.1

12.5

227

M03BX02

ATC

tizanidine; oral

1.6

12.5

681

5528

L28

ICPC

Limited function/disability (L)

2.4

12.5

110

489

M25.5

ICD-10 Finland

Pain in joint

1.7

12.5

281

1803

S01

ICD-10 Finland

Open wound of head

7.0

12.4

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.8

12.4

221

1317

B01AB05

ATC

enoxaparin; parenteral

1.8

12.4

238

1450

RS221

NOMESCO Finland

6.0

12.3

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

10.6

12.3

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

10.6

12.3

S61.9

ICD-10 Finland

Open wound of wrist and hand, part unspecified

3.7

12.2

144

NB3AA

NOMESCO Finland

Clavicle X-ray examination

5.9

12.1

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

12.1

552

4274

A02BC03

ATC

lansoprazole; oral

1.8

12.0

249

1553

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

47.2

11.9

RS222

NOMESCO Finland

8.0

11.9

K05.31

ICD-10 Finland

Periodontitis pronounced

2.4

11.9

103

454

S01.51

ICD-10 Finland

Open wound on lip

4.9

11.8

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.6

11.8

N06AA06

ATC

trimipramine; systemic

4.6

11.8

R52.2

ICD-10 Finland

Other chronic pain

4.3

11.8

103

N02AA05

ATC

oxycodone; systemic

2.4

11.8

105

467

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.5

11.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

11.7

546

4239

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

7.8

11.7

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

11.7

151

796

TNX30

NOMESCO Finland

Soft bandage, unspecified region

7.0

11.7

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

19.1

11.6

S06.9

ICD-10 Finland

Intracranial injury, unspecified

11.2

11.6

TNH32

NOMESCO Finland

Custom moulded split, ankle or foot

8.7

11.5

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.0

11.5

234

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

11.5

297

1979

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

13.8

11.5

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

13.8

11.5

S02.47

ICD-10 Finland

Multiple fracture of the upper jaw bone

121.2

11.4

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

11.4

203

1205

NB6AA

NOMESCO Finland

Humerus X-ray examination

6.1

11.4

N05AD01

ATC

haloperidol; systemic

4.4

11.4

Z50.1

ICD-10 Finland

Other physical therapy

3.3

11.4

180

L09

ICPC

Arm symptom/complaint

3.5

11.4

153

WX402

NOMESCO Finland

General anaesthesia

1.9

11.3

177

1005

AA3AD

NOMESCO Finland

CT of face

15.2

11.3

D09

ICPC

Nausea

3.2

11.3

186

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

6.6

11.3

EEC30

NOMESCO Finland

Reduction of zygomaticomaxillary fracture

35.4

11.3

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

35.4

11.3

R5599

NOMESCO Finland

Other rehabilitation service

4.4

11.2

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

3.5

11.2

155

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.0

11.2

221

SPAT1336

SPAT

Request for examination

4.1

11.2

109

S42.2

ICD-10 Finland

Fracture of upper end of humerus

3.9

11.2

119

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

4.7

11.2

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

12.9

11.2

Z01.7

ICD-10 Finland

Laboratory examination

2.2

11.2

121

594

F29

ICPC

Eye symptom/complaint other

2.5

11.1

351

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

4.3

11.1

S01.50

ICD-10 Finland

Open wound in oral cavity

8.1

11.1

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

8.7

11.1

L11

ICPC

Wrist symptom/complaint

2.5

11.0

357

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

11.0

367

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

43.8

10.9

S92.3

ICD-10 Finland

Fracture of metatarsal bone

3.3

10.9

169

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

7.0

10.9

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

7.0

10.9

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.6

10.9

305

L15

ICPC

Knee symptom/complaint

1.9

10.9

171

971

N03AF01

ATC

carbamazepine; oral, rectal

3.1

10.8

198

S42.0

ICD-10 Finland

Fracture of clavicle

3.5

10.8

143

G44.2

ICD-10 Finland

Tension-type headache

2.0

10.8

137

716

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

10.8

104

482

N05AN01

ATC

lithium; oral

3.6

10.8

133

N17

ICPC

Vertigo/dizziness

2.4

10.8

396

WZA90

NOMESCO Finland

Other doctors statement

1.7

10.8

250

1611

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.0

10.8

108

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.4

10.7

S02.69

ICD-10 Finland

Fracture of the lower jaw UNS

28.3

10.7

A02BC05

ATC

esomeprazole; systemic

1.6

10.7

357

2536

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.6

10.7

139

AA3AA

NOMESCO Finland

Facial bones X-ray examination

21.7

10.7

K29.2

ICD-10 Finland

Alcoholic gastritis

21.7

10.7

SPAT1283

SPAT

Restricted health certificate

1.7

10.7

258

1683

R07

ICPC

Sneezing/nasal congestion

2.4

10.7

391

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

10.6

103

480

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

7.1

10.6

L01

ICPC

Neck symptom/complaint

2.0

10.6

137

723

M54

ICD-10 Finland

Dorsalgia

2.0

10.5

139

741

F34.1

ICD-10 Finland

Dysthymia

3.2

10.5

169

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.9

10.4

Y08.8

ICD-10 Finland

Assault by other specified means by other known person

+∞

10.4

S02.65

ICD-10 Finland

Fracture of the symphysis mandipulae

+∞

10.4

N06AA09

ATC

amitriptyline; systemic

2.4

10.4

370

A99

ICPC

Disease/condition unspecnature/site

2.6

10.4

305

N05AD03

ATC

melperone; systemic

7.8

10.4

-60

ICPC

Result test/procedure

3.1

10.4

181

SPAT1307

SPAT

Psychosocial counselling and guidance

2.4

10.4

382

M95.0

ICD-10 Finland

Acquired deformity of nose

12.2

10.4

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.9

10.4

222

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

32.8

10.3

S02.66

ICD-10 Finland

Fracture of the angulus mandipulae

32.8

10.3

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.8

10.3

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

8.9

10.3

K02.9

ICD-10 Finland

Dental caries, unspecified

5.0

10.3

Y90.8

ICD-10 Finland

Blood alcohol level of 240 mg/100 ml or more

23.6

10.3

M54.8

ICD-10 Finland

Other dorsalgia

3.1

10.2

178

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.7

10.2

124

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.5

10.2

OAB43

SPAT

0.5

10.2

107

1866

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

10.2

173

K04.09

ICD-10 Finland

Pulpit UNS

2.8

10.2

253

XX9XW

NOMESCO Finland

8.0

10.1

L84

ICPC

Back syndrome without radiat pain

3.1

10.1

174

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

11.4

10.1

L08

ICPC

Shoulder symptom/complaint

1.9

10.0

168

974

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.4

10.0

147

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

10.0

724

6113

R55

ICD-10 Finland

Syncope and collapse

2.4

10.0

389

U13

ICPC

Bladder symptom/complaint other

4.8

10.0

A91

ICPC

Abnormal result investigation NOS

3.3

10.0

153

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

3.9

10.0

106

D06

ICPC

Abdominal pain localized other

2.4

10.0

359

X78

ICD-10 Finland

Intentional self-harm by sharp object

6.8

9.9

F41.00

ICD-10 Finland

Moderate panic disorder

4.6

9.9

S02.70

ICD-10 Finland

Multiple fractures involving skull and facial bones, closed

16.9

9.9

Z08

ICPC

Social welfare problem

6.0

9.9

R41.0

ICD-10 Finland

Disorientation, unspecified

5.5

9.9

RS121

NOMESCO Finland

10.7

9.8

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

4.8

9.7

F43.00

ICD-10 Finland

Acute stress reaction mild

3.7

9.7

114

U02

ICPC

Urinary frequency/urgency

2.3

9.7

404

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

9.7

775

6671

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.9

9.6

U07

ICPC

Urine symptom/complaint other

3.5

9.6

125

L16

ICPC

Ankle symptom/complaint

2.2

9.6

453

TND33

NOMESCO Finland

Custom moulded brace or cast, wrist or hand

6.4

9.6

WYA30

SPAT

8.5

9.6

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

9.5

128

686

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

9.2

9.5

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

10.1

9.5

ZXA10

NOMESCO Finland

Bilateral

1.9

9.5

150

852

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.6

9.5

121

M01AE02

ATC

naproxen; oral, rectal

1.5

9.5

570

4600

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

4.2

9.5

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.6

9.5

116

N06AX12

ATC

bupropion; oral

2.2

9.5

471

A02BC01

ATC

omeprazole; systemic

1.7

9.5

213

1356

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

2.0

9.5

127

679

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.1

9.5

171

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

9.4

330

SPAT1240

SPAT

Therapeutic discussion

1.9

9.4

136

746

T74.2

ICD-10 Finland

Sexual abuse

30.3

9.4

Z29

ICPC

Social problem NOS

4.1

9.4

S71.1

ICD-10 Finland

Open wound of thigh

5.9

9.4

X99.0

ICD-10 Finland

Assault by sharp object by spouse or partner

+∞

9.4

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.9

9.4

S02.11

ICD-10 Finland

Fracture of base of skull, open

21.9

9.4

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

3.0

9.4

181

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.9

9.3

145

820

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.9

9.3

R06.0

ICD-10 Finland

Dyspnoea

1.7

9.3

190

1174

S61.8

ICD-10 Finland

Open wound of other parts of wrist and hand

3.3

9.3

145

K70.1

ICD-10 Finland

Alcoholic hepatitis

9.6

9.3

N05BA06

ATC

lorazepam; systemic, sublingual

2.9

9.3

190

S52.5

ICD-10 Finland

Fracture of lower end of radius

2.3

9.3

391

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.1

9.3

105

524

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

4.4

9.3

LCH11

NOMESCO Finland

Pharmacologic abortion

3.1

9.3

168

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

7.4

9.2

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

13.8

9.2

P02

ICPC

Acute stress reaction

2.8

9.2

215

H53.2

ICD-10 Finland

Diplopia

3.7

9.2

104

W17

ICD-10 Finland

Other fall from one level to another

2.7

9.2

231

S27.0

ICD-10 Finland

Traumatic pneumothorax

6.8

9.2

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

5.0

9.2

S21

ICPC

Skin texture symptom/complaint

2.1

9.1

104

520

N76.0

ICD-10 Finland

Acute vaginitis

2.6

9.1

258

K04.0

ICD-10 Finland

Pulpitis

1.9

9.1

141

792

N05AA01

ATC

chlorpromazine; systemic, rectal

4.6

9.1

S01.3

ICD-10 Finland

Open wound of ear

6.3

9.1

SPD00

NOMESCO Finland

Fitting and preparation of total teeth prosthesis

11.6

9.1

N06AX26

ATC

vortioxetine; oral

2.3

9.0

369

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

9.0

425

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

15.7

9.0

X84

ICD-10 Finland

Intentional self-harm by unspecified means

15.7

9.0

L03.9

ICD-10 Finland

Cellulitis, unspecified

4.3

9.0

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.8

9.0

101

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

9.0

351

ZZA00

NOMESCO Finland

Split skin graft

4.4

9.0

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

8.9

311

RS120

NOMESCO Finland

18.8

8.9

NDJ64

NOMESCO Finland

Internal fixation of fracture of wrist or hand wire, rod, cerclage or pin

4.2

8.9

S04

ICPC

Lump/swelling localized

2.2

8.9

433

WX890

NOMESCO Finland

Intesive care monitoring

12.6

8.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

8.8

403

TND34

NOMESCO Finland

Custom moulded functional brace, wrist or hand

9.6

8.8

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.8

8.7

210

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

8.7

467

R60.0

ICD-10 Finland

Localized oedema

2.3

8.7

384

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

8.7

157

933

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

4.6

8.7

X23

ICPC

Fear sexually transm dis female

2.7

8.7

211

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.7

8.7

R42

ICD-10 Finland

Dizziness and giddiness

1.8

8.7

158

941

J01MA02

ATC

ciprofloxacin; systemic

1.5

8.6

331

2410

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

4.2

8.6

Z02.7

ICD-10 Finland

Issue of medical certificate

2.4

8.6

306

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

11.7

8.6

F10.05

ICD-10 Finland

Alcohol-related acute intoxication with coma

11.7

8.6

F43.01

ICD-10 Finland

Acute stress reaction moderate

4.5

8.6

K08.3

ICD-10 Finland

Retained dental root

2.4

8.6

327

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

8.6

416

N79

ICPC

Concussion

10.1

8.5

S50.0

ICD-10 Finland

Contusion of elbow

3.4

8.5

122

F10.07

ICD-10 Finland

Pathological alcohol intoxication

27.7

8.5

F19.39

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS

90.7

8.4

X15

ICPC

Vaginal symptom/complaint other

3.5

8.4

107

K04.08

ICD-10 Finland

Other specified pulpit

2.0

8.4

101

517

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

4.9

8.4

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.8

8.4

SPF10

NOMESCO Finland

Demanding repatation of teeth prosthesis

6.8

8.4

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

7.9

8.4

IEV99

NOMESCO Finland

Other psychiatric network intervention

7.9

8.4

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.8

8.4

197

U01

ICPC

Dysuria/painful urination

2.6

8.4

239

K04.1

ICD-10 Finland

Necrosis of pulp

1.9

8.3

128

720

F32

ICD-10 Finland

Depressive episode

2.4

8.3

316

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

8.3

506

WX204

NOMESCO Finland

Axillary plexus blockaced

3.2

8.3

135

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

6.3

8.3

WX882

NOMESCO Finland

High dependency care

4.1

8.3

Z09

ICPC

Legal problem

9.5

8.3

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

9.5

8.3

N05CD02

ATC

nitrazepam; oral

9.5

8.3

S90.0

ICD-10 Finland

Contusion of ankle

4.5

8.3

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.5

8.2

262

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

14.6

8.2

S97

ICPC

Chronic ulcer skin

2.8

8.2

177

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

202

330

7.09

121.90

5.1

3.3

—

(3033658) Prothrombin time (PT) actual/Normal

574

2260

3.82

117.62

5.9

3.9

92.6

94.1

0.76

558

2200

(4198724)

109

13.94

114.86

4.3

4.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

309

863

4.41

101.28

3.6

2.6

u/l

40.1

94.5

0.50

263

753

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

12.31

91.32

2.1

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

26.09

78.79

1.2

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

455

1903

3.17

78.74

3.1

1.8

1.4

12.37

414

1746

(3020191) Ethanol [Moles/volume] in Serum or Plasma

10.34

78.62

2.3

1.5

promille

1.9

1.3

2.03

(3011288) Drugs identified in Urine by Screen method

213

545

4.50

76.96

7.9

3.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

234

652

4.18

75.46

5.3

2.4

—

(3016879) Cocaine [Presence] in Urine

257

781

3.87

73.27

5.2

2.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

654

3475

2.83

71.35

4.8

3.3

u/l

37.3

32.5

2.92

625

3304

(3000764) Benzodiazepines [Presence] in Urine

263

842

3.68

69.17

5.2

2.3

—

(3028300) Cannabinoids [Presence] in Urine

263

851

3.64

67.99

5.1

2.3

—

(3027944) Amphetamines [Presence] in Urine

259

835

3.64

67.28

5.1

2.2

—

(3027008) Opiates [Presence] in Urine

261

848

3.62

66.98

4.3

2.0

—

(40758558) Short blood count panel - Blood

491

2321

2.82

65.93

7.8

6.9

—

(36304419) Bacteria [Presence] in Urine

477

2231

2.83

65.24

3.3

2.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

370

1532

3.00

63.17

3.5

3.2

ng/l

238.1

724.8

2.54

243

1029

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

323

1256

3.11

61.43

3.0

2.6

e6/l

2.9

2.1

0.64

164

638

(3030467) Casts [#/volume] in Urine by Automated count

467

2230

2.73

60.51

3.4

2.8

e6/l

0.3

0.4

1.22

337

1622

(3018095) Leukocytes [#/volume] in Urine

555

2908

2.62

59.34

4.2

3.4

e6/l

51.9

70.8

0.24

368

1986

(3002582) Erythrocytes [#/volume] in Urine

493

2445

2.67

58.91

3.5

2.9

e6/l

31.9

135.4

1.15

362

1835

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

326

1323

2.97

57.04

2.8

2.4

e6/l

0.7

0.9

0.45

167

697

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

8.39

55.46

5.3

3.9

—

(3018418) pH of Serum or Plasma

458

2251

2.62

55.03

3.9

4.2

7.4

1.12

424

(3014111) Lactate [Moles/volume] in Serum or Plasma

214

696

3.50

54.13

7.1

7.5

mmol/l

1.4

0.05

204

670

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

151

388

4.28

53.53

3.8

3.7

mmol/l

24.0

24.3

0.54

137

355

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

601

3426

2.44

51.74

6.6

6.1

mmol/l

1.2

3.43

567

3156

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

724

4507

2.42

50.76

7.3

6.2

umol/l

11.2

11.4

0.20

694

4306

(3000991) Gas panel - Venous blood

196

645

3.41

48.39

9.2

9.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

266

1064

2.90

46.93

3.6

2.9

umol/l

7.2

7.6

0.14

216

926

(3024561) Albumin [Mass/volume] in Serum or Plasma

590

3471

2.31

45.60

5.9

5.2

g/l

36.1

37.1

3.62

554

3277

(46235355) HIV 1 and 2 tests - Meaningful Use set

504

2776

2.36

45.44

2.4

2.0

—

(3002032) Base excess in Venous blood by calculation

197

677

3.26

45.20

3.7

3.8

mmol/l

1.5

2.0

0.85

159

543

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

631

3829

2.29

45.16

6.8

mmol/l

1.2

2.51

565

3271

(3021447) Carbon dioxide [Partial pressure] in Venous blood

198

686

3.24

44.80

3.7

3.8

kpa

5.9

0.01

186

668

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

954

7072

2.42

39.99

9.4

7.3

u/l

79.0

75.9

1.57

909

6716

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

510

2949

2.22

39.68

2.1

1.7

pmol/l

91.5

96.5

2.09

302

1629

(3024354) Oxygen [Partial pressure] in Venous blood

166

561

3.25

38.90

3.0

kpa

5.1

4.7

1.45

153

544

(42870588) Differential panel, method unspecified - Blood

528

3120

2.19

38.67

6.4

6.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

338

1662

2.41

38.40

1.9

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

228

929

2.77

38.28

8.7

7.7

mmol/l

104.0

104.2

0.27

223

908

(3013650) Neutrophils [#/volume] in Blood by Automated count

790

5478

2.18

38.03

11.1

9.6

e9/l

4.3

4.0

2.67

662

4828

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

151

489

3.37

37.89

1.5

1.4

—

(3023368) Bacteria identified in Blood by Culture

394

2090

2.29

37.42

6.8

4.2

—

(3022096) Basophils/100 leukocytes in Blood

671

4389

2.13

37.37

7.0

6.5

0.6

0.7

0.99

628

4161

(3044640) Blood type and Crossmatch panel - Blood

461

2618

2.20

36.95

2.7

2.2

—

(3002385) Erythrocyte distribution width [Ratio]

1104

8896

2.89

36.50

24.5

13.4

13.7

13.4

4.19

1099

8729

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

8.18

36.41

1.8

1.6

iu/ml

1384965.4

1229625.0

—

(3006504) Eosinophils/100 leukocytes in Blood

683

4538

2.10

36.01

7.0

6.3

2.8

0.08

639

4288

(3003396) Base excess in Arterial blood by calculation

206

828

2.78

35.33

8.2

8.9

mmol/l

0.5

1.1

1.03

161

664

(3042936) Bacteria identified in Isolate by Culture

271

1254

2.48

34.84

2.5

2.1

—

(3019069) Monocytes/100 leukocytes in Blood

682

4567

2.07

34.75

7.3

6.6

8.4

8.5

0.70

639

4349

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

205

831

2.75

34.54

1.8

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

9.21

34.36

1.9

4.2

umol/l

170.3

162.9

0.03

(3018010) Neutrophils/100 leukocytes in Blood

690

4671

2.05

33.76

7.0

6.1

55.8

56.2

0.40

649

4447

(3013826) Glucose [Moles/volume] in Serum or Plasma

732

5074

2.05

33.40

6.6

4.6

mmol/l

6.5

6.6

0.75

697

4716

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

205

847

2.69

33.21

1.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

203

835

2.70

33.17

8.2

8.9

kpa

11.9

12.8

1.25

194

807

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

203

835

2.70

33.17

8.3

8.9

kpa

5.2

5.1

0.35

194

804

(3024928) Oxygen saturation in Venous blood

162

4.86

32.81

2.3

2.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

774

5499

2.05

32.68

4.7

3.5

e6/l

674.2

1052.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

279

1350

2.37

32.25

4.0

3.5

mmol/l

0.8

4.55

253

1281

(3026782) Osmolality of Urine

309

1569

2.28

31.88

2.8

2.6

mosm/kgh2o

545.8

573.7

1.03

248

1345

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

122

387

3.38

31.50

10.3

10.9

mmol/l

23.8

24.3

0.85

117

372

(3002030) Lymphocytes/100 leukocytes in Blood

689

4735

2.00

31.49

7.1

6.3

28.9

29.2

0.30

648

4491

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

259

1232

2.39

31.01

3.2

2.9

mmol/l

2.4

1.95

210

1089

(3018677) aPTT in Platelet poor plasma by Coagulation assay

254

1217

2.36

29.81

2.0

2.1

29.3

29.6

0.38

247

1185

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

125

417

3.22

29.71

8.4

11.5

—

(3006315) Basophils [#/volume] in Blood

694

4852

1.95

29.39

7.1

6.3

e9/l

0.0

1.10

575

4284

(3021879) Hepatitis B virus core Ab [Presence] in Serum

236

1108

2.39

28.94

1.8

1.5

—

(3001604) Monocytes [#/volume] in Blood

691

4848

1.94

28.70

7.0

6.3

e9/l

0.6

3.96

573

4285

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

356

1989

2.10

28.45

2.5

2.1

—

(3013115) Eosinophils [#/volume] in Blood

707

5022

1.92

28.03

7.5

6.6

e9/l

0.2

1.60

595

4504

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

375

2159

2.05

27.48

1.9

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

170

703

2.64

27.23

8.9

9.9

g/l

124.5

125.5

0.22

164

679

(3015377) Calcium [Moles/volume] in Serum or Plasma

429

2609

1.97

26.81

3.2

3.3

mmol/l

2.3

2.4

0.30

378

2369

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

407

2432

1.99

26.75

2.6

2.1

u/l

292.4

255.6

0.28

380

2315

(3016502) Oxygen saturation in Arterial blood

176

747

2.58

26.71

8.8

9.4

94.9

96.2

1.41

171

723

(3000850) Epithelial cells [#/volume] in Urine

305

1641

2.13

26.69

2.5

e6/l

5.1

5.4

0.12

269

1440

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

325

1803

2.08

26.16

2.3

2.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

295

1581

2.13

26.00

1.7

1.5

nmol/l

19.5

20.2

0.42

278

1410

(3009508) Creatinine [Moles/volume] in Urine

431

2664

1.94

25.41

4.8

3.4

mmol/l

8.5

8.8

0.49

385

2296

(3019198) Lymphocytes [#/volume] in Blood

695

5010

1.86

25.27

7.2

6.3

e9/l

2.1

2.0

1.68

592

4498

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

344

1981

2.01

24.81

2.7

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

294

3.30

23.39

1.4

1.3

—

(3021589) Normoblasts [#/volume] in Blood

609

4293

1.81

23.05

9.4

8.7

e9/l

0.0

0.53

458

3561

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

105

375

2.96

22.10

1.7

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

194

942

2.25

21.59

2.2

2.1

—

(1761868) Lipid panel - Serum or Plasma

290

4639

0.51

21.59

2.1

2.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

119

471

2.69

20.65

10.6

10.4

0.6

0.7

1.48

119

466

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

226

1196

2.08

20.13

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1139

9999

2.40

19.82

20.6

11.6

mmol/l

139.3

139.7

6.38

1128

9740

(3023103) Potassium [Moles/volume] in Serum or Plasma

1142

10042

2.41

19.71

20.7

11.7

mmol/l

3.9

4.0

4.04

1128

9764

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

201

3.52

19.52

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

210

1095

2.10

19.41

2.2

1.6

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

15.65

19.38

1.1

1.7

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

15.65

19.38

1.1

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

234

3.30

19.12

2.8

3.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

787

6178

1.72

18.81

4.3

3.6

—

(3044889) 12 lead EKG panel

821

6527

1.73

18.68

3.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1152

10222

2.42

18.52

19.2

11.1

mg/l

24.7

21.8

2.13

983

7832

(3042517) Benzodiazepines panel - Urine

11.33

18.02

1.7

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

565

4094

1.69

17.89

4.1

3.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

314

1936

1.83

17.58

3.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

237

3.16

17.43

1.7

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

945

7906

1.77

16.99

4.9

3.0

u/l

64.4

45.9

5.78

900

7582

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

157

770

2.19

16.88

2.8

2.4

g/l

0.2

1.16

142

724

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

152

742

2.19

16.52

2.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

410

2773

1.71

16.48

3.5

2.6

u/l

55.8

56.8

0.19

393

2607

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

163

3.48

15.75

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1088

9576

1.97

15.71

16.8

9.6

ml/min/173m2

96.7

91.5

12.43

880

7813

(3003458) Phosphate [Moles/volume] in Serum or Plasma

192

1043

1.99

15.67

6.6

mmol/l

1.0

0.11

178

987

(3009466) Valproate [Moles/volume] in Serum or Plasma

213

3.11

15.22

6.0

5.7

umol/l

373.4

373.7

0.01

182

(3009542) Hematocrit [Volume Fraction] of Blood

1146

10303

2.19

15.20

23.7

11.3

41.1

41.7

2.77

1007

8560

(3026008) Bacteria identified in Urine by Culture

290

1815

1.78

15.18

3.3

2.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

163

3.42

15.04

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

328

2142

1.72

14.71

1.9

1.7

mg/l

1.0

0.9

0.32

237

1568

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

143

3.52

14.37

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

216

3.02

14.25

1.2

1.1

—

(3032080) INR in Blood by Coagulation assay

431

3050

1.63

14.09

7.0

6.4

inr

1.1

0.04

1004

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

309

2.66

14.01

2.7

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

287

1832

1.73

13.88

2.2

2.1

mg/l

2.7

2.8

0.44

241

1607

(3013707) Erythrocyte sedimentation rate by Westergren method

835

6926

1.60

13.72

3.4

3.7

mm/h

11.7

8.9

5.44

788

6523

(3019309) Folate [Moles/volume] in Red Blood Cells

197

1130

1.88

13.58

1.5

1.7

nmol/l

1001.8

1152.2

1.32

150

890

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

106

3.86

13.50

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

352

2421

1.63

12.67

1.6

1.7

mmol/l

1.8

1.5

2.02

332

2112

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1016

8933

1.70

12.39

4.9

4.1

mu/l

1.9

2.1

0.35

970

8388

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

4.67

12.16

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

137

725

2.00

11.94

1.9

3.1

1.8

1.7

0.25

125

665

(44816559) Phosphatidylethanol [Mass/volume] in Blood

311

2.50

11.83

1.9

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

229

2.75

11.74

1.3

1.4

ug/g

304.3

315.0

0.11

129

(3020779) Urea [Moles/volume] in Serum or Plasma

133

710

1.98

11.30

6.7

8.5

mmol/l

7.3

8.2

0.69

123

683

(3023410) Appearance of Cerebral spinal fluid

116

3.44

11.16

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

163

3.02

11.08

1.8

1.5

—

(3000494) Fungus identified in Specimen by Culture

189

1138

1.78

11.02

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

475

3597

1.51

10.86

2.6

2.3

nmol/l

66.8

72.6

4.01

445

3335

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

110

564

2.04

10.46

1.6

—

(36660697) Celiac disease serology panel - Serum

145

834

1.83

9.81

1.1

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

435

2.13

9.61

2.9

3.1

g/l

136.6

133.8

0.52

427

(3019150) Specific gravity of Urine by Refractometry

284

1971

1.57

9.48

4.0

3.0

kg/l

1.0

2.32

246

(3051611) Lipemic interference index of Serum or Plasma

3.92

9.43

3.7

4.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

138

799

1.82

9.13

15.2

15.1

inr

1.0

1.2

2.81

112

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

847

7352

1.46

8.87

3.9

3.6

pmol/l

14.3

14.5

2.83

789

6844

(3007566) Smooth muscle Ab [Titer] in Serum

337

2.21

8.68

1.3

titre

66.7

84.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

10.07

8.65

1.1

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

475

2.01

8.60

1.9

2.6

ng/l

97.6

118.9

0.33

418

(3017509) Phencyclidine [Presence] in Urine

6.90

8.45

2.2

—

(3011648) Oxygen content in Venous blood

3.73

8.20

2.4

2.3

13.0

12.3

0.36

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

176

2.61

8.07

2.9

2.1

titre

480.0

1320.0

—

(3036489) Thrombin time

368

2.10

8.05

1.7

2.0

21.1

21.5

0.33

326

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

349

2.13

7.97

2.3

2.7

0.6

0.63

338

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

285

2.24

7.83

2.4

g/l

3.9

3.7

0.46

274

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

133

801

1.74

7.69

4.4

3.0

—

(3051651) Icteric interference index of Serum or Plasma

3.78

7.37

4.0

4.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

447

1.94

7.23

6.0

8.7

mmol/l

24.3

24.6

0.27

420

(21494755) Public health laboratory ask at order entry panel

118

1891

0.59

7.13

1.2

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

296

2.11

6.77

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

296

2.11

6.77

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

209

1452

1.53

6.77

1.9

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

193

2.38

6.70

1.5

1.6

g/l

0.3

0.7

0.47

176

(42529406) Shigella sp [Presence] in Stool by Culture

298

2.10

6.66

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

334

2.03

6.57

1.8

2.0

92.5

93.8

0.16

313

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

300

2.09

6.55

2.0

2.3

197.6

177.0

1.08

289

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1170

11082

1.74

6.38

13.0

8.8

u/l

34.9

30.7

4.01

1153

10794

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

3.37

6.29

1.9

2.3

nmol/l

126.5

128.8

0.04

(3007164) IgA [Mass/volume] in Serum or Plasma

285

2137

1.43

6.25

1.4

g/l

2.7

2.3

1.50

144

1436

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

967

0.48

6.16

3.4

3.7

28.4

29.9

0.39

707

(3013139) Helicobacter pylori Ag [Presence] in Stool

586

1.75

6.10

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

235

2.17

6.04

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

303

2.03

6.02

1.8

1.9

g/l

1.4

1.5

0.26

267

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

329

2546

1.39

6.00

1.8

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

3.23

5.88

11.5

8.7

u/ml

1785.7

23469.2

—

(3003181) Sodium [Moles/volume] in Urine

2.85

5.86

1.8

1.3

mmol/l

54.1

67.9

0.62

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.54

5.81

1.4

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

179

1244

1.51

5.76

2.2

2.4

umol/l

14.3

14.6

0.19

171

1162

(40768804) Tissue Pathology biopsy report

432

3521

1.34

5.62

2.0

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

116

2.62

5.58

1.7

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

250

2.08

5.56

1.1

1.3

mmol/l

3.9

3.7

0.49

236

(40761511) CBC panel - Blood by Automated count

1154

10949

1.62

5.51

14.5

9.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

166

2.33

5.48

1.9

2.3

g/l

136.8

133.2

0.30

121

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

155

1056

1.53

5.47

2.4

2.5

25.0

0.02

140

927

(3001122) Ferritin [Mass/volume] in Serum or Plasma

496

4139

1.33

5.45

2.8

2.7

ug/l

132.5

125.7

0.22

467

3925

(3025130) Human papilloma virus identified in Specimen

124

2.54

5.40

2.0

1.8

—

(3019060) Gas panel - Arterial blood

462

1.78

5.39

4.9

6.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

464

1.77

5.31

1.5

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

255

2.04

5.29

1.5

e6/l

316.5

1458.0

0.81

208

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

255

2.04

5.29

1.5

1.4

e6/l

20.1

13.8

0.28

200

(3004789) Transferrin [Mass/volume] in Serum or Plasma

166

1156

1.50

5.29

2.4

g/l

2.4

0.19

156

1079

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

189

2.21

5.23

2.0

2.7

u/ml

0.2

0.3

1.70

(3000093) Morphology [Interpretation] in Blood Narrative

3.16

5.20

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

537

1.71

5.16

1.6

mu/l

273.1

280.3

0.13

488

(40760892) CBC W Ordered Manual Differential panel - Blood

179

2448

0.69

5.11

4.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

100

1543

0.62

5.10

1.6

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

3.78

5.10

1.7

1.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

232

2.07

5.06

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

232

2.07

5.06

1.5

g/l

4.2

4.0

0.56

165

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

232

2.07

5.06

1.5

g/l

7.5

7.2

0.37

175

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.93

5.05

4.3

3.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

2.09

5.03

1.5

g/l

3.5

3.1

1.37

171

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

450

1.76

5.00

1.3

miu/ml

131.6

246.8

2.54

221

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.97

4.72

1.8

2.2

umol/l

18.8

17.1

0.17

(3026493) Urate [Moles/volume] in Serum or Plasma

302

2387

1.35

4.69

2.3

2.5

umol/l

354.7

4004.0

5.27

273

2175

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

102

655

1.61

4.67

1.3

—

52.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

178

1288

1.44

4.67

2.3

nmol/l

13.9

14.2

0.16

159

1189

(3003327) Ova and parasites identified in Stool by Light microscopy

371

1.79

4.59

1.7

1.8

—

(40768797) Stomach Pathology biopsy report

162

1156

1.46

4.57

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1016

9485

1.36

4.52

4.1

3.6

mmol/l

6.0

5.8

2.16

963

8894

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

278

1.91

4.51

1.2

1.4

mg/l

480.9

483.9

0.02

266

(3004716) Salmonella sp identified in Stool by Organism specific culture

606

1.61

4.48

1.5

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

124

848

1.51

4.32

3.2

4.4

u/l

233.5

235.3

0.05

113

814

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.90

4.26

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

297

3640

0.76

4.12

3.5

2.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.65

4.07

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.65

4.07

1.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

524

4536

1.26

4.00

4.7

4.0

estimate

0.0

0.50

881

(3039443) Prostate specific Ag panel - Serum or Plasma

344

0.31

3.99

1.2

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.47

3.98

9.6

8.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.04

3.97

1.1

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

962

8962

1.31

3.96

4.9

4.6

mmol/mol

38.2

38.7

0.88

917

8548

(3009261) Glucose [Presence] in Urine by Test strip

527

4572

1.26

3.93

3.1

2.9

estimate

0.0

0.80

825

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

165

2.09

3.89

1.2

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1041

0.60

3.88

1.3

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

187

1411

1.38

3.86

1.3

titre

205.9

436.6

3.28

261

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

296

2398

1.31

3.80

1.3

u/ml

1.2

1.7

0.39

699

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

12.05

3.76

1.7

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

116

806

1.48

3.76

1.5

2.5

g/l

11.0

10.4

0.65

744

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

953

0.60

3.65

6.3

5.5

—

(3035350) Ketones [Presence] in Urine by Test strip

518

4521

1.25

3.57

3.1

2.9

estimate

0.0

0.50

848

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.47

3.56

1.1

—

(3044941) Cell count panel - Synovial fluid

124

2.20

3.56

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

472

1.60

3.54

3.0

2.6

u/l

8946.8

4737.0

0.56

195

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.19

3.50

2.4

1.7

—

(3022621) pH of Urine by Test strip

484

1.58

3.42

2.9

2.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

3.12

3.37

1.1

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

161

2.01

3.36

1.3

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

5.74

3.34

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

186

2368

0.75

3.30

3.8

3.2

estimate

0.0

1.08

849

(3027974) Hepatitis B virus e Ag [Presence] in Serum

8.60

3.26

1.5

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.76

3.24

2.8

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.59

3.20

1.0

2.3

—

(3019225) pH of Specimen

687

0.57

3.16

2.7

3.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

383

1.62

3.14

1.9

1.7

—

(3013512) EKG study

165

2119

0.75

3.10

3.2

3.1

—

(3021788) Differential panel - Synovial fluid

139

2.04

3.07

1.3

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

124

909

1.40

3.06

2.1

nmol/l

376.2

360.1

0.40

115

856

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

622

1.48

3.04

3.7

4.9

ug/l

14.2

22.0

0.31

497

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

133

2.05

3.02

1.3

1.4

nmol/l

0.6

0.25

127

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

524

1.52

3.02

3.4

4.4

ng/l

75.0

84.1

0.45

479

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.25

2.97

2.0

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

294

0.37

2.97

2.5

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.35

2.91

1.8

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

204

1629

1.30

2.88

1.3

iu/ml

32.0

27.5

0.12

520

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

275

0.36

2.87

2.6

1.7

—

(3007463) Buprenorphine [Presence] in Urine

6.69

2.87

1.2

4.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

212

1703

1.29

2.87

2.4

2.8

ng/l

1057.9

873.4

0.43

165

1380

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

260

1.72

2.86

2.1

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

165

1.90

2.82

2.3

2.5

kpa

8.5

0.07

155

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

591

1.47

2.80

2.0

2.2

ug/l

7.9

8.4

0.09

542

(3035320) C reactive protein [Mass/volume] in Body fluid

2.48

2.79

2.5

2.1

—

(3020393) Adenovirus Ag [Presence] in Stool

8.36

2.75

1.2

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

153

1.92

2.72

2.1

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.52

2.70

1.1

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

496

1.50

2.70

2.0

3.3

e9/l

74.6

72.8

0.13

371

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

2.19

2.68

1.2

1.3

nmol/l

1.0

1.4

0.93

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

133

1.97

2.66

1.3

nmol/l

0.1

0.5

—

(3000492) Spirometry study

159

1242

1.32

2.64

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

141

1.93

2.61

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

134

1.96

2.61

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

338

1.59

2.60

1.2

1.3

—

1380.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

635

1.43

2.59

1.7

1.9

nmol/l

36.9

36.3

0.11

623

(3048689) Calprotectin [Mass/mass] in Stool

178

1418

1.30

2.57

2.7

2.6

ug/g

121.2

134.9

0.28

148

1166

(4010399)

594

1.44

2.56

1.5

1.4

—

(3045788) Cell count panel - Pleural fluid

2.74

2.55

2.0

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

186

1.79

2.54

2.2

2.5

mmol/l

23.9

24.4

0.28

167

(3041096) Erythrocytes [Presence] in Urine by Automated

226

2720

0.79

2.54

2.9

2.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

129

1.96

2.51

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.30

2.41

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.30

2.41

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.30

2.41

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

267

1.63

2.37

3.6

4.0

u/ml

209.6

4690.1

0.65

231

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

222

1837

1.25

2.36

2.0

2.3

ug/l

0.6

0.7

0.43

151

928

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.27

2.35

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.27

2.35

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.27

2.35

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

3.12

2.22

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

2.22

0.0

1.1

—

1547.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

579

1.41

2.18

2.6

3.6

pmol/l

4.5

4.7

0.80

522

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

295

0.47

2.18

1.3

1.4

—

(3021901) Oxygen saturation in Capillary blood

129

1.88

2.17

1.9

2.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

632

1.39

2.15

1.4

1.7

g/l

1.8

1.3

0.82

594

(3012516) Albumin [Mass/volume] in Urine

259

2201

1.22

2.15

2.9

3.5

mg/l

298.9

457.6

0.25

180

1481

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

190

1.70

2.11

1.8

1.2

—

(3002256) Pathology report gross observation

135

1067

1.30

2.09

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

1213

11895

1.48

2.07

27.0

15.7

e12/l

4.6

4.7

12.31

1191

11633

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

103

1.96

2.06

8.1

5.7

mg/l

9.3

9.8

0.19

(3021440) Promyelocytes/100 leukocytes in Blood

695

0.66

2.05

5.0

4.8

0.1

0.14

177

(3000475) Leukocytes [#/volume] in Synovial fluid

177

1.71

2.03

1.4

1.7

e6/l

11546.2

11618.0

0.00

136

(3035637) Corticotropin [Mass/volume] in Plasma

111

1.91

2.01

1.9

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.09

2.01

3.4

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.09

2.01

3.4

2.8

—

(3000963) Hemoglobin [Mass/volume] in Blood

1213

11900

1.47

2.01

27.1

15.8

g/l

138.4

141.3

9.16

1208

11770

(3010813) Leukocytes [#/volume] in Blood

1213

11901

1.47

2.00

27.0

15.8

e9/l

7.2

6.6

20.52

1191

11628

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.35

1.96

1.0

1.2

—

(40768806) Pleura Pathology biopsy report

2.37

1.95

1.5

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

235

1.59

1.92

2.1

3.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

106

1.90

1.91

1.1

1.0

—

(3007461) Platelets [#/volume] in Blood

1210

11873

1.44

1.91

27.1

15.8

e9/l

255.8

252.1

1.03

1191

11627

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

121

1.83

1.89

1.3

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

325

1.50

1.88

3.3

3.7

mmol/l

25.0

25.1

0.07

314

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.40

1.85

2.1

1.4

e6/l

5946.7

21976.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.40

1.85

1.1

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

3.54

1.84

2.7

4.6

umol/l

47.3

38.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

108

1.87

1.82

1.3

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

2.28

1.81

2.0

1.4

e6/l

3843.6

1890.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

192

1.63

1.79

1.5

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

117

1.81

1.75

1.1

1.5

pmol/l

338.2

348.5

0.04

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

886

8441

1.17

1.74

4.1

3.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

762

0.71

1.73

1.3

1.6

—

(3025159) Blasts/100 leukocytes in Blood

668

0.69

1.71

4.6

4.9

0.2

0.00

154

(4027681)

1.89

1.71

1.2

—

(3012441) Differential panel - Pleural fluid

2.30

1.70

2.1

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

572

1.35

1.69

1.4

iu/l

20.4

23.2

0.36

485

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.39

1.68

4.9

1.4

umol/l

27.8

28.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

676

0.70

1.67

4.0

4.6

1.1

0.6

0.62

149

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

105

1.82

1.63

1.1

mg/l

292.8

278.5

0.31

(40761535) Cells panel - Urine sediment

625

0.69

1.61

3.0

3.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

413

1.40

1.61

1.6

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

264

2313

1.18

1.58

3.5

4.2

mg/mmol

7.6

9.9

0.44

178

1541

(3017181) Myelocytes/100 leukocytes in Blood

735

0.72

1.55

4.9

4.7

0.9

0.04

194

(40761536) Microorganisms panel - Urine sediment

780

0.73

1.55

4.0

3.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

169

1.61

1.53

1.4

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

142

0.42

1.52

1.8

1.3

ug/l

1.8

2.9

—

129

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.17

1.50

1.0

1.1

iu/ml

127.3

192.0

0.77

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.87

1.50

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

344

3106

1.15

1.38

3.3

2.9

ng/l

29.2

36.7

0.26

163

1747

(3009214) Lutropin [Units/volume] in Serum or Plasma

495

1.33

1.38

1.4

u/l

6.6

7.0

0.13

419

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

182

1.55

1.38

1.1

1.2

u/ml

1.6

4.8

0.97

(3003694) ABO and Rh group [Type] in Blood

325

2931

1.15

1.33

1.5

—

(3049717) Cytology report of Urine Cyto stain

233

1.47

1.32

2.1

2.3

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

1.31

0.0

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.78

1.28

1.2

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

2.78

1.28

1.4

10.9

—

(4034850)

292

0.61

1.28

9.4

6.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

468

1.32

1.25

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

1.75

1.25

1.9

1.3

mosm/kgh2o

281.1

286.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

279

1.41

1.23

1.4

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

116

1.65

1.21

1.2

1.4

nmol/l

—

(40760888) Immunoglobulin light chains.free panel - Serum

132

1.60

1.21

1.4

2.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

190

1.48

1.17

1.4

1.8

g/l

0.7

0.8

0.41

151

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

176

1532

1.17

1.16

1.3

1.2

u/ml

4.7

10.5

1.32

674

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

1.16

0.0

1.2

—

0.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

1.16

0.0

1.2

—

108.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

275

1.39

1.14

1.2

u/ml

302.9

248.9

0.38

178

(3024891) Influenza virus A+B Ag [Presence] in Specimen

344

1.35

1.14

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

344

1.35

1.14

1.5

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.69

1.14

1.3

1.5

mmol/l

11.9

12.6

0.14

(3022313) Gas panel - Capillary blood

353

0.67

1.12

2.6

3.2

—

(3036603) Volume of Urine

1.90

1.12

1.7

—

1952.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

285

1.38

1.11

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

585

1.26

1.11

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.26

1.10

1.6

2.2

ug/l

217.4

51.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.26

1.10

1.0

2.7

mg/l

20355.4

69.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

965

9924

0.88

1.09

3.3

3.4

mmol/l

1.5

1.4

2.95

909

9408

(3013727) Leukocytes other/100 leukocytes in Blood

2.39

1.09

4.4

2.8

49.8

45.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.96

1.09

1.1

2.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.96

1.09

1.1

2.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

2.19

1.08

1.0

ng/l

983.9

676.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

2.19

1.08

1.0

ng/l

29.6

31.0

—

(3005033) Fetal Nuchal fold Thickness US

271

1.38

1.05

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

2.13

1.05

1.0

ng/l

312.4

214.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.13

1.05

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

204

1.43

1.03

1.1

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

273

1.37

1.02

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

1.89

1.01

1.0

1.4

nmol/l

165.9

150.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

180

1.45

1.01

1.2

u/ml

2.4

4.9

1.07

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

476

1.27

1.01

1.6

1.9

pmol/l

186.5

216.9

1.45

456

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.01

1.00

4.3

3.3

—

(1616796) Gas panel - Central venous blood

189

1.44

0.99

3.4

3.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.81

0.98

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

2.18

0.98

2.6

2.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

258

1.37

0.97

1.8

2.0

iu/l

3.4

4.5

0.54

(4035726)

644

1.23

0.94

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

116

0.51

0.94

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

116

0.51

0.94

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

116

0.51

0.94

1.3

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

118

0.51

0.94

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

118

0.51

0.94

1.3

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.90

0.94

5.6

3.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.62

0.94

1.1

—

(3000330) Specific gravity of Urine by Test strip

321

1.32

0.94

2.7

2.6

—

(3025941) Bacteria identified in Stool by Culture

601

1.23

0.91

1.4

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

152

1.46

0.88

1.5

1.4

mmol/l

7.0

7.3

0.15

108

(4268621)

119

1.52

0.88

2.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

2.00

0.87

1.2

u/l

27.2

10.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

216

0.64

0.86

2.5

ug/min

386.7

118.0

—

128

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.82

0.86

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

298

0.70

0.86

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.60

0.84

1.1

1.0

u/l

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

296

0.70

0.83

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

114

0.52

0.83

1.3

1.4

—

(40768443) Skin Pathology biopsy report

346

1.28

0.82

1.1

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

249

1.33

0.82

3.5

4.6

mmol/l

1.7

1.3

0.48

244

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.71

0.80

1.3

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

704

1.19

0.79

1.2

iu/ml

200.4

160.0

0.28

295

(4038314)

0.00

0.78

0.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.77

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.77

0.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.77

0.0

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1059

10390

1.12

0.76

4.2

4.0

mmol/l

2.9

0.66

1004

9852

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

132

1.45

0.76

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

208

0.67

0.74

1.1

1.0

u/ml

2.6

2.4

—

102

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

266

2459

1.10

0.73

2.8

3.0

20.7

21.6

0.25

815

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.00

0.72

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.80

0.72

1.3

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

109

0.55

0.72

1.2

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

143

0.63

0.70

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

274

0.73

0.70

1.7

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

1.56

0.70

1.3

1.5

nmol/l

1.4

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

285

0.73

0.69

1.2

1.9

—

(40768793) Breast Pathology biopsy report

157

0.63

0.69

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

516

0.81

0.67

1.4

1.8

mg/l

3.4

4.0

0.27

346

(3045424) Erythrocytes [Presence] in Urine

179

0.67

0.66

1.3

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

189

0.68

0.64

2.8

4.1

e9/l

5.2

4.3

0.46

189

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

129

0.62

0.64

1.1

1.9

—

(3008898) HLA-B27 [Presence]

507

1.19

0.63

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

332

3125

1.08

0.62

3.0

3.2

ug/l

3.0

1.6

0.59

298

2885

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.64

0.62

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.67

0.61

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.67

0.61

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

335

1.23

0.60

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.60

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.60

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.60

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

185

0.70

0.58

1.3

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

173

0.69

0.57

1.7

1.5

—

233.4

—

(4133840)

1.72

0.57

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

229

0.74

0.56

1.0

1.1

u/ml

2.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

159

0.69

0.54

4.5

3.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

151

1.33

0.54

1.3

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.45

0.53

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.54

0.53

1.5

3.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.52

0.52

1.2

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

146

1336

1.10

0.52

1.5

—

(3020891) Body temperature

287

1.23

0.52

4.2

4.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.50

0.51

1.0

1.6

u/l

8.8

13.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

281

0.78

0.51

1.8

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.42

0.50

1.5

1.7

mmol/l

6.8

7.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

268

0.78

0.49

1.2

1.1

u/ml

8.4

6.7

0.10

144

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

145

1.32

0.49

1.5

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

256

0.78

0.48

1.1

u/ml

0.4

1.8

1.19

107

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

105

1159

0.90

0.48

1.8

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

199

0.75

0.46

1.0

u/ml

0.0

0.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.39

0.46

1.2

—

(3045414) Leukocytes [Presence] in Urine

366

1.18

0.45

2.0

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

228

1.23

0.45

3.5

2.1

nmol/l

0.7

0.9

0.92

205

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

256

1.22

0.44

1.1

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.40

0.44

1.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

470

1.16

0.44

2.2

3.2

mmol/l

1.6

1.4

0.14

342

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.62

0.43

1.0

1.2

—

(1002224) Polysomnography panel

699

1.12

0.42

1.1

—

(3042631) Mycobacterium sp identified in Specimen

0.64

0.42

1.3

3.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.64

0.42

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.42

1.0

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.56

0.42

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3048879) Bone marrow aspiration report

0.00

0.41

0.0

2.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

3.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.36

0.41

1.4

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.40

0.0

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

687

0.88

0.40

2.3

2.2

ml/min/173m2

82.0

75.8

0.54

264

(3037121) Protein [Mass/volume] in Urine

287

1.19

0.40

4.7

4.0

g/l

0.3

0.2

0.08

148

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

353

1.17

0.39

1.4

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

192

0.78

0.38

2.7

4.6

55.1

56.5

0.14

192

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

147

0.75

0.37

7.0

3.3

—

(3037756) Immunofixation for Serum or Plasma

116

1.30

0.37

1.3

—

(40768800) Prostate Pathology biopsy report

125

1.28

0.37

1.1

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

213

0.80

0.37

1.0

1.1

u/ml

1.7

4.6

—

(40768795) Lymph node Pathology biopsy report

1.39

0.37

1.0

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.63

0.35

6.6

2.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.31

0.33

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.31

0.33

1.2

1.4

mmol/l

5.9

6.2

—

(3015183) Erythrocyte sedimentation rate

0.69

0.33

1.0

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

493

1.12

0.32

1.8

2.1

u/l

43.8

39.2

0.75

453

(3010726) Horse dander IgE Ab [Units/volume] in Serum

263

0.83

0.32

1.0

1.1

u/ml

0.5

2.4

—

(21494434) Karyotype in Bone marrow

1.25

0.29

1.0

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.25

0.29

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

292

0.85

0.29

1.1

u/ml

0.5

2.1

1.65

116

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

185

1.19

0.29

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

158

1.21

0.28

2.4

16.5

0.02

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.32

0.28

1.5

1.9

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.29

0.28

1.4

3.2

u/ml

1682.4

692.4

—

(3009343) pH of Capillary blood

489

1.11

0.28

2.3

3.1

7.4

0.02

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

131

1.22

0.27

1.4

1.3

—

(3022145) Colonoscopy Study observation

1058

0.93

0.26

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.27

0.26

1.5

2.0

—

(40768441) Liver Pathology biopsy report

1.30

0.26

1.3

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

1.25

0.25

2.8

8.4

mmol/l

7.5

7.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

273

1.14

0.25

2.3

2.1

ug/l

0.8

1.6

0.86

245

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

330

1.12

0.25

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

330

1.12

0.25

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

114

1.23

0.25

2.2

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

397

1.11

0.25

1.5

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

161

1688

0.95

0.25

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

331

1.12

0.24

1.4

—

(3045142) Bone marrow Pathology biopsy report

0.73

0.24

2.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

332

1.12

0.23

1.4

—

(3017704) Immunofixation for Urine

1.28

0.23

1.0

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

496

1.09

0.22

2.3

3.1

kpa

5.2

0.31

466

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

116

1.21

0.22

4.6

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

116

1.21

0.22

2.3

3.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

220

0.86

0.21

1.1

1.9

—

(3004451) EKG impression Narrative

1.19

0.21

2.4

1.2

—

(3034426) Prothrombin time (PT)

1.19

0.21

1.0

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.21

0.0

1.6

—

9.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.21

0.0

1.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.21

0.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(4306422)

182

1.16

0.21

1.2

—

(4015189)

0.00

0.21

0.0

4.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.21

0.0

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

0.20

0.0

3.4

—

4911.9

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

61.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.20

0.0

8.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

183

1.15

0.20

1.6

1.5

nmol/l

0.3

0.07

141

(40757494) Bilirubin.total [Moles/volume] in Blood

1.20

0.19

1.5

2.2

—

17.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

238

0.88

0.18

1.1

1.2

—

3.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

0.85

0.18

1.2

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.21

0.18

1.3

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

153

0.85

0.18

1.2

1.4

—

(4062490)

110

1.18

0.17

1.0

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

110

1.18

0.17

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.22

0.17

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.75

0.17

4.8

3.3

mg/l

4.3

8.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.14

0.16

1.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

162

0.86

0.16

2.3

2.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

204

0.88

0.16

1.2

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.11

0.16

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

172

0.87

0.15

3.2

3.1

mg/l

25.0

25.1

—

103

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.78

0.15

1.5

3.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.13

0.15

1.1

2.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

381

1.08

0.15

1.5

1.6

iu/ml

0.8

0.2

0.34

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

352

1.08

0.15

2.6

2.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

244

0.90

0.14

2.0

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.79

0.14

1.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.79

0.14

1.0

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

106

0.85

0.13

1.0

2.1

—

(3023419) Bacteria identified in Sputum by Culture

107

0.84

0.13

1.4

3.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

161

1.12

0.13

1.6

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

190

1.11

0.12

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

179

0.89

0.12

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

133

1.13

0.12

1.3

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

302

0.93

0.11

1.7

1.4

g/l

1.1

1.2

0.61

287

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

172

1.11

0.11

1.1

1.2

—

7.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

347

1.07

0.11

2.5

2.2

u/ml

74.5

37.8

0.37

332

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1023

10276

0.98

0.11

3.6

3.7

mmol/l

1.3

1.4

4.28

971

9761

(3024471) HLA-A [Type]

1.14

0.10

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.14

0.10

2.0

—

343.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.11

0.09

1.0

1.2

—

(4024509)

1.09

0.09

1.4

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.04

0.09

5.0

1.3

—

(40768446) Kidney Pathology biopsy report

1.09

0.09

1.8

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

1.0

1.9

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.05

0.08

1.9

2.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.03

0.08

1.7

2.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.84

0.07

1.3

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.86

0.07

1.0

2.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.80

0.07

3.2

2.3

34.7

33.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

609

1.04

0.07

2.4

1.9

—

(3010421) pH of Blood

225

1.07

0.07

5.3

3.6

7.4

1.12

187

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

184

0.92

0.07

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

214

0.93

0.07

1.9

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.87

0.06

1.5

1.3

—

68.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

132

0.91

0.06

1.5

1.8

nmol/l

20.4

20.9

0.09

125

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

603

1.03

0.05

1.6

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

149

1.07

0.05

1.1

2.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

110

1.09

0.05

1.0

1.2

—

(3017732) Neutrophils [#/volume] in Blood

666

0.97

0.05

2.4

2.8

e9/l

4.4

4.0

0.56

561

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

150

0.93

0.04

1.1

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1033

10312

1.01

0.03

3.7

3.8

mmol/l

4.7

4.8

2.00

986

9831

(3004809) Band form neutrophils/100 leukocytes in Blood

108

0.93

0.03

3.1

3.6

1.0

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

1.07

0.02

1.0

1.9

—

(4094501)

269

0.97

0.02

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

113

1.06

0.02

1.3

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

164

0.98

0.00

1.1

g/l

1.6

1.4

0.74

149

(3014148) Varicella zoster virus Ab [Titer] in Serum

176

1.02

0.00

1.1

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

336

1.01

0.00

1.1

u/ml

1.4

5.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

188

1.01

0.00

2.6

3.3

—

2354.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

252

0.99

0.00

2.2

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

131

0.99

0.00

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

155

1548

1.00

0.00

1.5

1.6

pmol/l

63768526.8

33629404.2

0.19

138

1353

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

175

1.03

0.00

1.4

pmol/l

69.4

126.9

0.45

170

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

215

1.02

0.00

1.3

1.9

—

(44806118)

115

1.04

0.00

1.2

1.8

—

(44790048)

115

1.04

0.00

1.2

1.8

—

(44790049)

115

1.04

0.00

1.2

1.8

—

(44790047)

115

1.04

0.00

1.2

1.8

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

18.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.00

0.0

1.0

—

13.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

202.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

12.8

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.9

—

459.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.3

—

(3007916) DNA double strand Ab [Titer] in Serum

0.00

0.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.0

—

(3005570) Glucose [Moles/volume] in Urine

0.95

0.00

2.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.0

2.0

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

2.0

—

10.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.7

—

1.5

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(44813793)

0.92

0.00

1.2

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.93

0.00

1.1

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.93

0.00

1.1

1.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

151.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

0.98

0.00

2.6

1.6

u/field

0.6

4.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3012898) Urea [Moles/volume] in Urine

0.00

0.0

1.4

—

184.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.01

0.00

2.0

2.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.89

0.00

1.4

2.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.94

0.00

1.8

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.93

0.00

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

0.00

0.0

1.3

—

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012501) Base excess in Blood by calculation

190

1.00

0.00

6.0

3.7

mmol/l

2.0

2.4

0.31

122

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.88

0.00

1.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.93

0.00

1.1

1.8

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.1

—

33.8

—

(4281824)

1.02

0.00

1.2

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.93

0.00

1.0

—

6.2

—

(44806420)

0.00

0.0

2.0

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_OTHER_MALTR_SYNDR1 – Other maltreatment syndromes

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other maltreatment syndromes

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other maltreatment syndromes (VWXY20_OTHER_MALTR_SYNDR1)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints